Persky Marla
- SEC CIK
- 0001270354
In the past year, 1 open-market sale filing worth $91.5K and no purchases.
Current role at each company
- XERS Xeris Biopharma Holdings, Inc.Directoras of Jun 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $91.5K
- 1 filing
- Net
- −$91.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Persky Marla as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Persky MarlaDirector | SSale | −15.5K | $5.90 | −$91.5K | −10.9%126.5K after | 10b5-1 |
| Sep 12, 2025 (view filing) | Sep 11 | 1 day | Persky MarlaDirector | SSale | −15.5K | $7.72 | −$119.7K | −9.8%142.0K after | 10b5-1 |
| Nov 15, 2023 (view filing) | Nov 14 | 1 day | Persky MarlaDirector | PPurchase | +6.37K | $1.58 | +$10.1K | New position6.37K after |